Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -143.83x is 167% below its 1-year average of -53.83x, near the low end of its 1-year range (-143.83x–7.41x).
As of the fiscal period ended Saturday, September 30, 2023. 167.19% below its 12-month average of -53.83x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2023 (2023-09-30): -143.83x.
INTEREST COVERAGE RATIO
-143.83x
INTEREST COVERAGE RATIO AVG TTM
-53.83x
INTEREST COVERAGE RATIO AVG 3Y
-53.83x
INTEREST COVERAGE RATIO AVG 5Y
-53.83x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-167.19%
CURRENT VS 3Y AVG
-167.19%
CURRENT VS 5Y AVG
-167.19%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-2156.09%
vs the sector median at left
The Joint Corp.
Market Cap
$102.78M
Interest Coverage Ratio
-143.83x
TTM Avg
-53.83x
3Y Avg
-53.83x
5Y Avg
-53.83x
Market Cap
$101.85M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$103.60M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.15M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.07M
Interest Coverage Ratio
-1.82x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.91M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.98M
Interest Coverage Ratio
-5.63x
TTM Avg
53.06x
3Y Avg
67.81x
5Y Avg
43.09x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Joint Corp. (JYNT) | $102.78M | -143.83x | -53.83x | -53.83x | -53.83x |
| OnKure Therapeutics, Inc. (OKUR)vs › | $101.85M | N/A | N/A | N/A | N/A |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.18M | N/A | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.60M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $105.15M | N/A | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $105.07M | -1.82x | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $97.71M | -48.13x | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.91M | N/A | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | -5.63x | 53.06x | 67.81x | 43.09x |
| Immunic, Inc. (IMUX)vs › | $107.06M | N/A | N/A | N/A | N/A |
Interest Coverage
-143.8x
Debt/Equity
0.13
Current Ratio
1.83
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-09-30 | -143.83x |
| 2023-06-30 | -25.08x |
| 2022-12-31 | 7.41x |
| 2017-12-31 | -2.15x |
| 2016-12-31 | -382.11x |
